These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

243 related items for PubMed ID: 4155971

  • 21. The antiarrhythmic properties of BL-3677A.
    Buyniski JP, Gardier RW.
    J Pharmacol Exp Ther; 1974 Aug; 190(2):289-99. PubMed ID: 4449041
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Antiarrhythmic activity of four pteridine compounds in ouabain intoxication.
    Yeh BK, Francis JS, Gosselin AJ, Elias RA.
    Clin Pharmacol Ther; 1975 Feb; 17(2):141-5. PubMed ID: 235395
    [Abstract] [Full Text] [Related]

  • 25. The antiarrhythmic and cardiovascular properties of 1-dimethyl isopropylamino-3-(2-phenylphenoxy)-propan-2-ol chloride, UM-424.
    Kniffen FJ, Winokur S, Counsell RE, Lucchesi BR.
    J Pharmacol Exp Ther; 1976 Feb; 196(2):420-32. PubMed ID: 3643
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Comparative investigation of the effects of metoprolol, propranolol, practolol, and verapamil in the acute phase of experimental myocardial infarction.
    Bernauer W.
    Klin Wochenschr; 1982 Jan 15; 60(2):87-96. PubMed ID: 6121935
    [Abstract] [Full Text] [Related]

  • 28. Antiarrhythmic effects of bupuranolol against canine ventricular arrhythmias induced by halothane-adrenaline or two-stage coronary ligation.
    Hashimoto K, Tsukada T, Matsuda H, Nakagawa Y, Imai S.
    J Cardiovasc Pharmacol; 1979 Jan 15; 1(2):205-17. PubMed ID: 94390
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Antiarrhythmic and cardiovascular effects of MP 115.
    Allen JD, Deering AH, Kelly JG, Shanks RG.
    J Cardiovasc Pharmacol; 1983 Jan 15; 5(6):937-44. PubMed ID: 6196565
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Antiarrhythmic activity of bunolol, a new beta adrenergic blocking agent.
    Kaplan HR, Robson RD.
    J Pharmacol Exp Ther; 1970 Oct 15; 175(1):168-77. PubMed ID: 4394302
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Double blind cross-over study of the inotropic influence of Tiprenolol (DU21445) and propranolol in patients with ischaemic heart disease.
    Yan V, Sloman G.
    Aust N Z J Med; 1973 Oct 15; 3(5):467-73. PubMed ID: 4149632
    [No Abstract] [Full Text] [Related]

  • 38. Pirmenol hydrochloride (CI-845) and reference antiarrhythmic agents: effects on early ventricular arrhythmias after acute coronary artery ligation in anesthetized rats.
    Mertz TE, Kaplan HR.
    J Pharmacol Exp Ther; 1982 Nov 15; 223(2):580-6. PubMed ID: 7131307
    [Abstract] [Full Text] [Related]

  • 39. [Drug effects on blood pressure and heart rate in unanesthetized animals. (1). Effects of beta-blocking agents (author's transl)].
    Iizuka H, Nakagawa Y, Matsubara I, Imai S, Yanagita T.
    Nihon Yakurigaku Zasshi; 1977 May 15; 73(4):401-9. PubMed ID: 20392
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 13.